HDM3018

N/A

Report date: 2025/10/24 15:04:43

First In Class

Base Information

Drug NameHDM3018

Drug Alias NameHDM3018HDM-3018

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsPlaque psoriasisInflammatory Bowel DiseasesArthritis, Psoriatic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesHangzhou Zhongmei Huadong Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Zhongmei Huadong Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsPlaque psoriasisInflammatory Bowel DiseasesArthritis, Psoriatic

Inactive IndicationsN/A

Other Information

ATC CodeN/A